	Landscape of volatile organic compounds for differential diagnosis, pathological typing, and severity prediction in lung cancer: a large population-based prospective study. J Adv Res Xiang R, Hu P, Liu M, Dai W, Tian B, Li W, Liu X, Zhuang X, Yang X, Xie T, Hu B, He J, Ma K, Bie J, Shi Y, Liao J, Xie S, Yang X, Li J, Yang Y, Liao P, Xie T, Zhang Q, Luo H, Duan Y, Li Q. PMID: 41951045 [PubMed - as supplied by publisher]
	Mapping the mutational terrain of lung adenocarcinoma: A Danish cohort study of 880 patients. Cancer Treat Res Commun Georgsen JB, Jakobsen MV, Meldgaard P, Lade-Keller J, Jepsen P, Nielsen PS, Dyrborg L, Steiniche T. PMID: 41950707 [PubMed - as supplied by publisher]
	Corrigendum to "Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial": [Ann Oncol 36 (2025) 775-785]. Ann Oncol Felip E, Rojas CI, Schenker M, Kowalski DM, Casarini IA, Csöszi T, , Martins J, Calles Blanco A, Wang CC, Wang M, Ramirez Fallas RAL, Yoshioka H, Nair S, Song X, Deng X, Lala M, Eiras R, Takahashi T. PMID: 41951457 [PubMed - as supplied by publisher]
	SKYSCRAPER-02C: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer in China. J Thorac Oncol Lu S, Fang J, Yu Y, Fan Y, Dong X, Wang Z, Wang Q, Wang J, Cui J, Pan H, Wu Q, Lin C, Zhang L, Meng R, Liu C, Huang X, Patil NS. PMID: 41950998 [PubMed - as supplied by publisher]
	Less Is More, But Me-Too Should Not Be the Strategy for Lung Cancer Treatment in 2026. Am Soc Clin Oncol Educ Book Bortolot M, Saw SPL, Pietroluongo E, Rajath G, Patel A, Garassino M, Remon J. PMID: 41950438 [PubMed - indexed for MEDLINE]
	Multimodal Assessment of Biological Age Following Radiation Therapy Among Patients With Early-Stage NSCLC. JAMA Netw Open Lee G, Haugg F, Bontempi D, He J, Bitterman DS, Pai S, Guthier C, Fitzgerald KJ, Kozono DE, Kann BH, Aerts HJWL, Mak RH. PMID: 41949867 [PubMed - indexed for MEDLINE]
	Cost-effectiveness of pembrolizumab plus chemotherapy for metastatic non-small cell lung cancer: a head-to-head trial vs. real-world comparison. J Med Econ Teppala S, Koo J, Clarke S, Lu CY. PMID: 41949826 [PubMed - indexed for MEDLINE]
	Incidental discovery of second primary lung tumors in breast cancer patients: An institutional case series. Oncologist Iancu A, Gwin W, Vinayak S, Linden H, Specht J, Symonds L, Davidson N, Hunter N. PMID: 41949764 [PubMed - as supplied by publisher]
	Applications and challenges of multi-omics approaches in lung cancer research and precision treatment. Front Genet Zhang S, Xu R, Zheng Q, Chen B, Li W. PMID: 41948518 [PubMed]
	Prognostic Implications of Programmed Cell Death Ligand 1 Expression, Cluster of Differentiation 8-Positive T-Cell Infiltration, and Related Immunophenotypes in Invasive Mucinous Adenocarcinoma of the Lung: A Multicenter Study. MedComm (2020) Zhang G, Zheng C, Jia J, Li X, Wang L, Zhang L, Zhang Y, Yue M, Zhang S, Liu Y, Xue L, Xue Q, He J. PMID: 41948454 [PubMed]
	CLIC6 and ANLN: novel exosome-related prognostic markers and therapeutic targets in lung adenocarcinoma. Front Immunol Miao Y, Li T, Li R, Liu Y. PMID: 41948338 [PubMed - indexed for MEDLINE]
	Radon and Non-Cancer Pulmonary Health Effects in Children: A State of The Art Review. Pediatr Pulmonol Banzon TM, Koutrakis P, Garshick E, Gaffin JM, Phipatanakul W. PMID: 41947778 [PubMed - indexed for MEDLINE]
	Impact of Rural Hospital Closures on Survival Among Medicare Beneficiaries Diagnosed With Colorectal, Lung, Breast, and Prostate Cancer. J Rural Health Liu Z, Gao D, Martin T, Winegar R, Giordano SH, Kuo YF. PMID: 41947577 [PubMed - indexed for MEDLINE]
	Protocol for the development and validation of a risk score to predict risk of adverse events associated with systemic anti-cancer treatment in late-stage lung cancer: Lung Cancer Improved Decisions (LUCID). Diagn Progn Res Almossawi O, Steventon L, Keogh R, Diaz-Ordaz K, Wang Z, Challenger A, Dodwell D, Forster M, Man KKC, Wei L, Masento S, Januszewski A, Chambers P. PMID: 41947265 [PubMed]
	Research on lung nodule detection in X-ray plain films based on improved YOLOv12 model. Sci Rep Mao M, Hong C, Zhang Y, Huang H, Chu J, Fu L. PMID: 41946809 [PubMed - indexed for MEDLINE]
	Subcutaneous atezolizumab for the treatment of non-small cell lung cancer. Ther Deliv González-Montero J, Rojas CI, Burotto M. PMID: 41946650 [PubMed - as supplied by publisher]
	Survival prediction in non-small cell lung cancer using layer-wise radiomics and stacked radscore integration: a multi-institutional study. Phys Med Kawahara D, Imano N, Kishi M, Fujiwara T, Kimura T, Murakami Y. PMID: 41946210 [PubMed - as supplied by publisher]
	An Integrative Approach to Lung Cancer Therapy: Linking the TGF-Î² (+869 C/T) Polymorphism to a Structurally Validated Natural Inhibitor. Asian Pac J Cancer Prev Abdulsahib NB, Hameed MA, Yousif RH, Jabir MS. PMID: 41945959 [PubMed - indexed for MEDLINE]
	The Prognostic Impact of Supraclavicular Lymph Node Metastases in Lung Cancer: Do We Need a Modification of the Current Staging System? Asian Pac J Cancer Prev Sohaib A, Sedeek HF, El Madawie M, Elabd NS, Abouelhassan U, Alhefny M. PMID: 41945947 [PubMed - indexed for MEDLINE]
	Tumor Lysis Syndrome in Lung Cancer Patients: A Review of the Literature. Asian Pac J Cancer Prev Siddiqui Z, Schab AR, Paracha A, Abid A, Rifai K, Huba M, Arshad M, Paracha M, Durrani U, Nair H, Ahmed B. PMID: 41945935 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 158682

Page 1 of 7935



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy